Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Laura on +44 (0) 1494 818026 or laura@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Laura Marsh
Account Manager
laura@zenopa.com
+44 (0) 1494 818026

Testimonials
I just wanted to take this opportunity to thank you for all your support throughout my interview process with the client.
Annie, 2012

Pfizer beats forecasts with second-quarter profits

3 August 2011 00:00 in Pharmaceutical Company Financials


Pfizer has reported second-quarter profits that exceeded analysts' estimates, despite revenue declining as a result of expiring patents.

The world's biggest pharmaceutical firm said profit excluding some items was 60 cents a share - one cent higher than the average estimate of 16 experts polled by Bloomberg.

Second-quarter revenues stood at $17 billion (10.3 billion pounds), a decrease of one percent compared with the corresponding period last year.

Ian Read, president and chief executive of Pfizer, said the performance was "in line with our expectations".

He added: "We will continue to invest in areas that will enhance our presence, expand the breadth of our portfolio and position our businesses to better capitalise on high-growth opportunities."

Pfizer is preparing to face generic competition to Lipitor - the world's best-selling drug - from November, when it will lose the exclusive rights to the cholesterol control treatment.

According to the firm's statement, sales of Lipitor stood at $2.59 billion in the second quarter of 2011.ADNFCR-8000103-ID-800682960-ADNFCR

Other news stories from 03/08/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd